Premier Research Names Bernard Sweeney as Executive Director, Medical Devices
News Oct 21, 2009
In this position, Mr. Sweeney will play a leading role in the operations, strategic planning, and corporate development of Premier Research’s growing portfolio of medical device business. He will be based in Premier Research’s Swiss office.
Mr. Sweeney has more than 20 years experience in medical device research and development, during which time he has supervised clinical trials leading to the market approval of more than 20 new products. He joins us from the British Standards Institute (BSi) where he had been the Director of Healthcare responsible for providing global regulatory approvals leading to market access for medical device companies across the world. Prior to his time at BSi, Mr Sweeney held positions at both government agencies and medical devices manufacturers including Medilink East Midlands and Femcare Nikomed Group.
“Mr. Sweeney is an exceptional addition to our team,” said Chris Nowell, Vice President, International Clinical Trial Management. “As we continue to expand our presence within the medical device market, Mr. Sweeney’s substantial clinical and management expertise will be beneficial in continuing to establish Premier Research as the industry leader.”
Huntsman Cancer Institute Joins National Clinical Trial Targeting AMLNews
Huntsman Cancer Institute (HCI) at the University of Utah (U of U) has been selected to participate in the Beat AML Master Trial, an innovative clinical trial sponsored by The Leukemia & Lymphoma Society (LLS). The clinical trial is testing several new targeted therapies for the treatment of patients with acute myeloid leukemia (AML). HCI is the only facility in the Mountain West offering this trial to AML patients.READ MORE
Study Extends Potential of Personalized Cell-based ImmunotherapiesNews
New methods developed for the study could be applied to devise personalized, cell-based immunotherapies for epithelial ovarian cancer or other types of tumorsREAD MORE